Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin®
Spexis AG / Key word(s): Financing/Partnership Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund...
Source: businessinsider.com